HOME >> BIOLOGY >> NEWS
Stanford's new antigen microarrays open window to better disease screening

STANFORD, Calif. - Your immune system normally protects against disease, but in some cases - such as with rheumatoid arthritis, lupus, and type-I diabetes - the immune system actually attacks your body. Until now, these disorders, called autoimmune diseases, have been difficult to diagnose and treat. But a new microarray-based technology developed at Stanford University Medical Center may help solve the problem.

Antigen microarrays, as reported in the March issue of Nature Medicine, give doctors a glimpse of which molecules (antigens) come under attack in an autoimmune disease. By identifying these antigens, doctors can pinpoint diseases and treatment options.

"Right now clinicians test each antigen separately - and each one can take weeks," said P.J. Utz, MD, assistant professor of immunology and rheumatology and senior author on the study. "These arrays could enable a clinician to diagnose the disease on the first visit."

The antigen microarrays - developed in collaboration with Lawrence Steinman, MD, professor of neurology and neurological sciences - consist of glass slides dotted with thousands of proteins and other molecules that are often attacked in autoimmune diseases. To use the microarray, doctors draw a blood sample from the patient and incubate it on the array. Those antibodies that attack molecules on the array will locate their target and latch on. Fluorescent molecules are then added to detect the antibodies, creating colored spots on the slide. From there, it's a matter of counting the spots to see which antigens the immune system recognized.

In normal people, the antibodies will ignore most antigens on the array. Diabetics, however, may produce arrays with spots corresponding to pancreas cell proteins, and people with rheumatoid arthritis produce spots that correspond to molecules found in the joints.

Utz and William Robinson, MD, PhD, a fellow in the division of immunolo
'"/>

Contact: Amy Adams
amyadams@stanford.edu
650-723-3900
Stanford University Medical Center
6-Mar-2002


Page: 1 2

Related biology news :

1. Researchers go fishing, pull out antigens
2. Hopkins researchers identify transplantation antigens among Sioux Indians
3. Cyclin B1 identified as a new tumor antigen and candidate for the development of a cancer vaccine
4. UC Berkeley group finds first prostate cancer antigen, providing hope for an eventual vaccine against the tumor
5. UroGenesys researchers discover new target antigen for prostate cancers
6. Library on a Slide: Whole genome microarrays for comparative genomics
7. Study by Tufts biologist provides window into progression of some degenerative diseases
8. Film found on windows after 9/11 reveals higher level of pollutants
9. Germ-free transparent fish open new window into gut development
10. Yeast mutations offer window into human disease
11. New findings are a window into the late stages of Lou Gehrigs disease

Post Your Comments:
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "iPhone 5S Fingerprint ... Report" report to their offering. ... the acquisition of AuthenTec in July 2012, Apple ... 5S. It is currently the only device of ...
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has ... North America Perimeter Security Systems Market" report to ... The North American perimeter security market is ... 2014 to 2019. Although the U.S. market holds a ... is expected to grow at a higher CAGR ...
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, ... publication of a study that pinpoints fine-scale differences in ... United States . Since immigrants first ... the United States has served as a ... illuminates how American history and the ongoing mixing of ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 323andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
(Date:12/19/2014)... Tigard, OR and Hershey, PA (PRWEB) December 19, ... (OTC Pink: BJCT), a leading developer and manufacturer ... has entered into an agreement with Immunomic Therapeutics, ... Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ ... receives an option for an exclusive Worldwide license ...
(Date:12/19/2014)... MA (PRWEB) December 19, 2014 Charm ... MRLAFMQ test for the Detection of Aflatoxin M1 in ... to receive independent third party validation. The peer reviewed ... Unit of the Institute for Agricultural and Fisheries Research ... Group. , Aflatoxin B1, the most toxic aflatoxin ...
(Date:12/19/2014)... 19, 2014 BioPlus Specialty Pharmacy ... announces the promotion of Nick Maroulis, Pharm.D. to the ... Services. , In this position, Dr. Maroulis will ... managing the directors of our multi-site pharmacies as the ... 1997 and during that time he has served in ...
(Date:12/19/2014)... Ill. , Dec. 19, 2014 Naurex ... develop novel drugs for diseases of the central nervous ... president and chief executive officer, will present at the ... Riedel,s presentation will take place at 3:00 p.m. PST ... Francis in San Francisco, Calif. ...
Breaking Biology Technology:Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
Cached News: